Study shows botanical formula fights prostate cancer

April 10th, 2012
A non-toxic, botanical formula controls aggressive human prostate tumors in mice, according to a peer-reviewed study in the The International Journal of Oncology. Researchers at Indiana University, Methodist Research Institute, showed the prostate formula significantly suppresses tumor growth in aggressive, hormone-refractory (androgen-independent) human prostate cancer cells. The study also demonstrated the formula has no toxic side effects, even at high dosages.

"This study is a milestone in the research of this formula, demonstrating its safety and effectiveness in treating human prostate cancer in an animal model," says researcher and formula inventor Dr. Isaac Eliaz. "These positive results offer a significant contribution to prostate cancer research and add to the growing body of published data substantiating the role of natural compounds in the treatment of prostate cancer."

The formula combines botanical extracts, phytonutrients, botanically-enhanced medicinal mushrooms and antioxidants. This is the third study from a major university to demonstrate the formula's ability to suppress tumor growth and metastasis. For more information on the formula, visit www.prostatehealthsolutions.org.

"Multiple studies have demonstrated that this prostate formula is a possible treatment for hormone-refractory prostate cancer," says lead researcher, Dr. Daniel Sliva.

The study found that the orally-administered formula suppressed tumor growth by 27 percent, compared to controls. In addition to significant reduction in tumor volume, the formula inhibited several genes (IGF2, NRNF2 and PLAU/uPA) that encourage cancer proliferation and metastasis. The formula also increased expression of CDKN1A, a gene that fights prostate cancer by inhibiting cancer-promoting cellular mechanisms.

By suppressing genes related to aggressive prostate cancer growth and proliferation, and increasing the expression of cancer-fighting genes, the formula demonstrates multiple anti-cancer mechanisms and genetic targets.

This pre-clinical in vivo study confirms previously published in vitro data, which showed the formula decreases the expression of PLAU/uPA genes in aggressive, hormone-independent prostate cancer cells.

Prior to this research, the formula was studied at Columbia University and the Cancer Research Laboratory, Methodist Research Institute, at Indiana University Health. These studies also showed the formula inhibits prostate cancer growth and proliferation.

More information:
www.spandidos-publications.com… 0.3892/ijo.2012.1344

Provided by Better Health Publishing

This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.

More news stories

Scientists develop pioneering new spray-on solar cells

(Phys.org) —A team of scientists at the University of Sheffield are the first to fabricate perovskite solar cells using a spray-painting process – a discovery that could help cut the cost of solar electricity.

SHERLOC to micro-map Mars minerals and carbon rings

(Phys.org) —An ultraviolet-light instrument on the robotic arm of NASA's Mars 2020 rover will use two types of ultraviolet-light spectroscopy, plus a versatile camera, to help meet the mission's ambitious ...

Ibuprofen relieves women's hurt feelings, not men's

(Medical Xpress)—For years, researchers have known that physical pain relievers such as ibuprofen can also help ease emotional pain, but new research suggests that ibuprofen has contrasting effects on men ...

Heavy metals and hydroelectricity

Hydraulic engineering is increasingly relied on for hydroelectricity generation. However, redirecting stream flow can yield unintended consequences. In the August 2014 issue of GSA Today, Donald Rodbell of ...